Shanghai MicroPort Endovascular MedTech Co., LtdSSE: 688016

Report for Q1 2026

Apr 30, 2026 · Issued by Shanghai MicroPort Endovascular MedTech Co., Ltd via Shanghai Stock Exchange

Filed with SSE · Apr 30, 2026

On 6ix: 6ix.com/news/report-for-q1-2026-433

Report for Q1 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Shanghai MicroPort Endovascular MedTech Co., Ltd on 6ix

Earlier from Shanghai MicroPort Endovascular MedTech

Notice on Convening the 2025 Annual General MeetingApr 23
Announcement on Implementation of Daily Related Transactions in 2025 and Estimated Daily Related Party Transactions in 2026Mar 31
Announcement on Voluntary Disclosure of Obtaining Medical Device Registration CertificateMar 14
Announcement on Voluntary Disclosure of the Thoracic Main Multibranch Stent Receiving Breakthrough Device Designation from the U.S. FDAMar 2
Announcement on Preliminary Earnings Estimate for 2025Feb 28

Later from Shanghai MicroPort Endovascular MedTech

Announcement on Resolutions of the 2025 Annual General MeetingMay 15
Announcement on Implementation of Dividend Distribution for 2025May 30
Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Medical Device and Medical Equipment IndustryAug 27
(688016)"Shanghai Microport Endovascular Medtech (Group) Co., Ltd."Announcement on Implementation of Dividend Distribution for the First Half of 2026Oct 14
(688016)"Shanghai Microport Endovascular Medtech (Group) Co., Ltd."Announcement on Attending the Q3 2026 Collective Performance Briefing of Listed Companies in Shanghai JurisdictionOct 30

All Shanghai MicroPort Endovascular MedTech news releases

Follow Shanghai MicroPort Endovascular MedTech into a list and get an email when it puts out news.

Follow Shanghai MicroPort Endovascular MedTech